Publicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (39)

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  2. Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 797-804

  3. Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney

    Redox Biology, Vol. 68

  4. The Clinical Profile of Patients with COPD Is Conditioned by Age

    Journal of Clinical Medicine, Vol. 12, Núm. 24

2022

  1. Decalogue for the selection of oral antibiotics for lower respiratory tract infections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 16-29

  2. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study

    Respiratory Research, Vol. 23, Núm. 1

  3. Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 59

  4. Laparoscopic Single-Port versus Mini-Laparoscopic Hysterectomy: An International Study

    Gynecologic and obstetric investigation, Vol. 87, Núm. 6, pp. 381-388

  5. Real-life burden of hospitalisations due to COPD exacerbations in Spain

    ERJ Open Research, Vol. 8, Núm. 3

  6. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients

    International journal of molecular sciences, Vol. 23, Núm. 18

  7. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19

    Science Progress, Vol. 105, Núm. 1

2021

  1. Clinical Management of COPD in a Real-World Setting. A Big Data Analysis

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 94-100

  2. Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E23-E28

  3. Tratamiento antibiótico oral de la exacerbación de la EPOC. Más allá de la COVID-19

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 429-440

2020

  1. Continuous home oxygen therapy

    Open Respiratory Archives, Vol. 2, Núm. 2, pp. 33-45

  2. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study

    Journal of Hematology and Oncology, Vol. 13, Núm. 1

  3. Pneumology in the Days of COVID-19

    Archivos de Bronconeumologia

  4. Reliability and validity of a stress scale in public employees from murcia (Spain)

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 23, pp. 1-11

  5. Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study

    CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286

  6. Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population

    Journal of Neurology, Vol. 267, Núm. 8, pp. 2362-2371